165 related articles for article (PubMed ID: 36580379)
1. Design and rationale of the Japanese Idiopathic Interstitial Pneumonias (JIPS) Registry.
Okuda R; Ogura T; Hisata S; Baba T; Kondoh Y; Suda T; Johkoh T; Iwasawa T; Tomioka H; Bando M; Azuma A; Inoue Y; Arai T; Nakamura Y; Miyamoto A; Miyazaki Y; Chiba H; Ishii H; Hamada N; Terasaki Y; Kuwahira I; Sato S; Kato S; Suzuki T; Sakamoto S; Nishioka Y; Hattori N; Hashimoto N; Morita S; Ichihara N; Miyata H; Hagiwara K; Nukiwa T; Kobayashi K
Respir Investig; 2023 Jan; 61(1):95-102. PubMed ID: 36580379
[TBL] [Abstract][Full Text] [Related]
2. Survival and acute exacerbation for patients with idiopathic pulmonary fibrosis (IPF) or non-IPF idiopathic interstitial pneumonias: 5-year follow-up analysis of a prospective multi-institutional patient registry.
Tsubouchi K; Hamada N; Tokunaga S; Ichiki K; Takata S; Ishii H; Kitasato Y; Okamoto M; Kawakami S; Yatera K; Kawasaki M; Fujita M; Yoshida M; Maeyama T; Harada T; Wataya H; Torii R; Komori M; Mizuta Y; Tobino K; Harada E; Yabuuchi H; Nakanishi Y; Okamoto I
BMJ Open Respir Res; 2023 Nov; 10(1):. PubMed ID: 37963676
[TBL] [Abstract][Full Text] [Related]
3. Comparison of clinical courses and mortality of connective tissue disease-associated interstitial pneumonias and chronic fibrosing idiopathic interstitial pneumonias.
Yıldırım F; Türk M; Bitik B; Erbaş G; Köktürk N; Haznedaroğlu Ş; Türktaş H
Kaohsiung J Med Sci; 2019 Jun; 35(6):365-372. PubMed ID: 30913371
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the Diagnostic Efficacies of Serological Markers KL-6, SP-A, SP-D, CCL2, and CXCL13 in Idiopathic Interstitial Pneumonia.
Xue M; Guo Z; Cai C; Sun B; Wang H
Respiration; 2019; 98(6):534-545. PubMed ID: 31665737
[TBL] [Abstract][Full Text] [Related]
5. A prospective survey of idiopathic interstitial pneumonias in a web registry in Japan.
Bando M; Sugiyama Y; Azuma A; Ebina M; Taniguchi H; Taguchi Y; Takahashi H; Homma S; Nukiwa T; Kudoh S
Respir Investig; 2015 Mar; 53(2):51-9. PubMed ID: 25745849
[TBL] [Abstract][Full Text] [Related]
6. Radiological pleuroparenchymal fibroelastosis-like lesion in idiopathic interstitial pneumonias.
Fujisawa T; Horiike Y; Egashira R; Sumikawa H; Iwasawa T; Matsushita S; Sugiura H; Kataoka K; Hashisako M; Yasui H; Hozumi H; Karayama M; Suzuki Y; Furuhashi K; Enomoto N; Nakamura Y; Inui N; Suda T
Respir Res; 2021 Nov; 22(1):290. PubMed ID: 34758816
[TBL] [Abstract][Full Text] [Related]
7. Prognosis after acute exacerbation in patients with interstitial lung disease other than idiopathic pulmonary fibrosis.
Miyashita K; Kono M; Saito G; Koyanagi Y; Tsutsumi A; Kobayashi T; Miki Y; Hashimoto D; Nakamura Y; Suda T; Nakamura H
Clin Respir J; 2021 Mar; 15(3):336-344. PubMed ID: 33197284
[TBL] [Abstract][Full Text] [Related]
8. Broader criteria of undifferentiated connective tissue disease in idiopathic interstitial pneumonias.
Kondoh Y; Johkoh T; Fukuoka J; Arakawa H; Tanaka T; Watanabe N; Sakamoto K; Kataoka K; Kimura T; Taniguchi H
Respir Med; 2015 Mar; 109(3):389-96. PubMed ID: 25682542
[TBL] [Abstract][Full Text] [Related]
9. Prognostic differences among patients with idiopathic interstitial pneumonias with acute exacerbation of varying pathogenesis: a retrospective study.
Kato M; Yamada T; Kataoka S; Arai Y; Miura K; Ochi Y; Ihara H; Koyama R; Sasaki S; Takahashi K
Respir Res; 2019 Dec; 20(1):287. PubMed ID: 31852459
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics of patients with familial idiopathic pulmonary fibrosis (f-IPF).
Krauss E; Gehrken G; Drakopanagiotakis F; Tello S; Dartsch RC; Maurer O; Windhorst A; von der Beck D; Griese M; Seeger W; Guenther A
BMC Pulm Med; 2019 Jul; 19(1):130. PubMed ID: 31319833
[TBL] [Abstract][Full Text] [Related]
11. Heterogeneity of incidence and outcome of acute exacerbation in idiopathic interstitial pneumonia.
Arai T; Kagawa T; Sasaki Y; Sugawara R; Sugimoto C; Tachibana K; Kitaichi M; Akira M; Hayashi S; Inoue Y
Respirology; 2016 Nov; 21(8):1431-1437. PubMed ID: 27460223
[TBL] [Abstract][Full Text] [Related]
12. Progressive fibrosing interstitial lung diseases: A new concept and indication of nintedanib.
Makino S
Mod Rheumatol; 2021 Jan; 31(1):13-19. PubMed ID: 32964766
[TBL] [Abstract][Full Text] [Related]
13. Deep learning diagnostic and severity-stratification for interstitial lung diseases and chronic obstructive pulmonary disease in digital lung auscultations and ultrasonography: clinical protocol for an observational case-control study.
Siebert JN; Hartley MA; Courvoisier DS; Salamin M; Robotham L; Doenz J; Barazzone-Argiroffo C; Gervaix A; Bridevaux PO
BMC Pulm Med; 2023 Jun; 23(1):191. PubMed ID: 37264374
[TBL] [Abstract][Full Text] [Related]
14. [Idiopathic interstitial pneumonias].
Lazor R; Letovanec I; Beigelman C
Rev Prat; 2014 Sep; 64(7):933-7, 939-40. PubMed ID: 25362773
[TBL] [Abstract][Full Text] [Related]
15. Genetics and Idiopathic Interstitial Pneumonias.
Chu SG; El-Chemaly S; Rosas IO
Semin Respir Crit Care Med; 2016 Jun; 37(3):321-30. PubMed ID: 27231858
[TBL] [Abstract][Full Text] [Related]
16. Nintedanib: A Review in Fibrotic Interstitial Lung Diseases.
Lamb YN
Drugs; 2021 Apr; 81(5):575-586. PubMed ID: 33765296
[TBL] [Abstract][Full Text] [Related]
17. Imaging Features of Idiopathic Interstitial Lung Diseases.
Batra K; Adams TN
J Thorac Imaging; 2023 Nov; 38(Suppl 1):S19-S29. PubMed ID: 37505195
[TBL] [Abstract][Full Text] [Related]
18. Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial.
Wells AU; Flaherty KR; Brown KK; Inoue Y; Devaraj A; Richeldi L; Moua T; Crestani B; Wuyts WA; Stowasser S; Quaresma M; Goeldner RG; Schlenker-Herceg R; Kolb M;
Lancet Respir Med; 2020 May; 8(5):453-460. PubMed ID: 32145830
[TBL] [Abstract][Full Text] [Related]
19. Multidisciplinary Approach to the Diagnosis of Idiopathic Interstitial Pneumonias: Focus on the Pathologist's Key Role.
Lucà S; Pagliuca F; Perrotta F; Ronchi A; Mariniello DF; Natale G; Bianco A; Fiorelli A; Accardo M; Franco R
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612431
[TBL] [Abstract][Full Text] [Related]
20. Impact of bronchoalveolar lavage lymphocytosis on the effects of anti-inflammatory therapy in idiopathic non-specific interstitial pneumonia, idiopathic pleuroparenchymal fibroelastosis, and unclassifiable idiopathic interstitial pneumonia.
Yamagata A; Arita M; Tachibana H; Tokioka F; Sugimoto C; Sumikawa H; Tanaka T; Yasui H; Fujisawa T; Nakamura Y; Suda T; Ishida T
Respir Res; 2021 Apr; 22(1):115. PubMed ID: 33879137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
